CR overview
| CR: | SMYD2 | |
| Accession: | Q9NRG4 | |
| Protein names: | N-lysine methyltransferase SMYD2 | |
| Function type: | Histone Modifier | |
| Histone type: | Writer | |
| Methytor type: | Unkown | |
| Aliases: | SET and MYND domain containing;Histone methyltransferases;SET-HMT | |
| PMID: | 33935284 31548876 34841684 | |
| Disease: | 2 | |
| Go term: | 19 | |
| Pathway: | 3 | |
| Hallmark: | -- | |
| Super Enhancer: | chr1:214449632-214471212 chr1:214444755-214477248 chr1:214453600-214471406 chr1:214434665-214513157 chr1:214434380-214471126 chr1:214572303-214580692 chr1:214573648-214579888 chr1:214534683-214630829 chr1:214559524-214579670 chr1:214576934-214594485 chr1:214576604-214593686 chr1:214559718-214604439 chr1:214485144-214536630 chr1:214489457-214529461 chr1:214316064-214332115 chr1:214504490-214629480 chr1:214296507-214340675 chr1:214279086-214340439 chr1:214275139-214342880 chr1:214278913-214341512 chr1:214385733-214394694 chr1:214506242-214560725 |
|
| Enhancer: |
chr1:214454770-214457240 chr1:214611500-214611870 chr1:214611910-214612360 chr1:214614540-214615200 chr1:214722230-214724520 chr1:214612540-214614500 chr1:214505540-214507540 chr1:214549780-214551300 chr1:214565050-214567030 chr1:214501070-214503510 chr1:214504410-214505360 chr1:214558130-214560180 chr1:214567120-214568240 chr1:214575120-214576220 chr1:214811340-214813260 chr1:214107260-214108350 chr1:214402000-214402720 chr1:214162060-214164240 chr1:214776660-214779150 chr1:214503620-214504290 chr1:214469160-214469330 chr1:214469880-214471220 chr1:214648800-214651250 chr1:214664880-214665150 chr1:214665650-214667150 chr1:214667280-214668930 chr1:214669120-214670160 chr1:214491480-214492200 chr1:214499400-214500960 chr1:214576300-214576460 chr1:214577550-214578800 chr1:214588070-214590550 chr1:214594620-214597110 chr1:214625320-214627500 chr1:214627690-214629490 chr1:214687400-214688410 chr1:214689060-214691160 chr1:214691380-214692280 chr1:214739220-214741280 chr1:214742470-214744690 chr1:214880660-214881840 chr1:215003630-215006020 chr1:215011510-215012060 chr1:215034440-215036850 chr1:215037960-215039230 chr1:215074510-215076930 chr1:215130020-215132460 chr1:215140620-215141950 chr1:215156350-215157270 chr1:215162390-215164580 chr1:215166520-215167530 chr1:215195090-215196570 chr1:215196580-215197750 chr1:215256780-215258890 chr1:215287030-215288740 chr1:215446630-215448300 chr1:215450570-215451570 chr1:215006220-215007380 chr1:214581290-214582860 chr1:214864670-214865920 chr1:214842890-214844170 chr1:214639530-214641750 chr1:214745570-214748000 chr1:214120280-214121200 chr1:214677440-214679000 chr1:214679900-214681540 chr1:214720260-214720940 chr1:214851360-214852130 chr1:214585100-214585450 chr1:214714530-214716770 chr1:214756960-214758880 chr1:214560270-214560870 chr1:214510480-214512010 chr1:214513100-214514500 chr1:214514560-214514990 chr1:215306640-215307400 chr1:214462810-214464840 chr1:214484450-214484900 chr1:214489670-214491310 chr1:214837920-214840390 chr1:214534680-214536680 chr1:214787260-214788170 chr1:214175100-214177400 chr1:214195060-214196480 |
|
| Promoter: |
chr1:214279102-214283102 |
ChIP-seq based regulatory details of SMYD2
| Sample ID | CR | Biosample type | Biosample term name | File accession | Experiment accession | Source |
|---|
Downstream target genes of SMYD2
Upstream regulatory details of SMYD2
Protein-protein interaction of SMYD2
Annotation of SMYD2
TCGA cancer survival map of SMYD2
Other information of SMYD2